Having trouble accessing articles? Reset your cache.

Optimer falls on 1Q13 financial results

Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) fell $2.11 (14%) to $12.81 on Friday after

Read the full 129 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE